StockData
Organigram Global Inc. logo

Organigram Global Inc. (OGI) stock

OGINasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 16, 2025Score 4/30
$0.72−0.10 (-12.62%)

Close on Nov 16, 2026Market cap $97.35MP/E –Yield –

Earnings

Organigram Global's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Organigram Global's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Organigram Global has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Organigram Global puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Organigram Global filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?